×

Jupiter Wellness Appoints Ardis Enterprises as the Exclusive Florida Market Distributor for its NoStingz and CaniSun Lines of Sunscreen

Jupiter Wellness Appoints Ardis Enterprises as the Exclusive Florida Market Distributor for its NoStingz and CaniSun Lines of Sunscreen
December 5, 2022adminTechUncategorized
JUPITER, FL / December 5, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness, announced today the appointment of Ardis Enterprises, LLC (“Ardis”) as its exclusive distributor for selling NoStingz and CaniSun sunscreen products in the Florida market. Established in 2020, Ardis is a leading distributor of sun care products, skateboards, and beach shop novelties in the State of Florida. Founded by Ben Ardis, with more than 20 years of experience in the industry, Ardis has become a trusted partner for over 500 beach and surf shops in Florida. The agreement with Ardis will enable Jupiter Wellness to expand its presence in the Florida market and meet the growing demand for high-quality sunscreen products. Jupiter Wellness’s range of sunscreen products are formulated with natural ingredients and backed by rigorous scientific testing. The Company’s NoStingz brand includes a line of patent-pending jellyfish sting prevention sunscreen that protects users from jellyfish and sea lice. “We are thrilled to partner with Ardis to expand our presence in the Florida market,” said the CEO of Jupiter Wellness. “Their commitment to providing the highest quality products to their customers makes them the perfect partner for us. We look forward to working together to bring our sunscreen products to more people in Florida.” About Jupiter Wellness Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The Company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements, and licensing royalties.
Copyright ©2023 all rights reserved